AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis

Clinical trial NCT02082262 · COMPLETED

Trial details

NCT number: NCT02082262
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Conjunctivitis, Allergic

Start date: 2014-03-01
Primary completion: 2014-07-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.